vimarsana.com
Home
Live Updates
Investegate |30 Technology Announcements | 30 Technology: 30
Investegate |30 Technology Announcements | 30 Technology: 30
Investegate |30 Technology Announcements | 30 Technology: 30 Technology's Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
Investegate announcements from 30 Technology, 30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
Related Keywords
London ,
City Of ,
United Kingdom ,
Edinburgh ,
Morningside ,
North Lanarkshire ,
Scotland ,
Divakar Ramakrishnan ,
Chris Wood ,
Syd Hanna ,
Lucy Featherstone ,
Chris Welsh ,
Amber Fennell ,
Royal College Of Surgeons Edinburgh ,
Convatec Group Plc For Several Applications ,
Head Of Research Development At Convatec ,
Technology Clinically Validated Antimicrobial Nitric Oxideplatform ,
Convatec Group Plc ,
Goodwin Procter ,
Technology Clinically Validated Antimicrobial Nitric Oxide Platform ,
Consilium Strategic Communications ,
Professor At Imperial College London ,
Several Applications ,
Nitric Oxide ,
Cystic Fibrosis ,
Group Executive Director ,
Chief Technology Officer ,
Advanced Wound ,
Social Care ,
Scottish Enterprise ,
Professor Chris Wood ,
Imperial College London ,
Royal College ,
Morningside Ventures ,
Investegate Announcements ,
Investegate Company Announcements ,
20 Technology ,
Lobenewswire ,
Lobenewswire And Globenewswire ,
Nw ,